Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
11.98
+0.43 (3.72%)
At close: Aug 13, 2025, 4:00 PM
11.78
-0.20 (-1.67%)
After-hours: Aug 13, 2025, 7:10 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $1.67 billion as of August 13, 2025. Its market cap has increased by 63.09% in one year.
Market Cap
1.67B
Enterprise Value
1.51B
1-Year Change
63.09%
Ranking
Category
Stock Price
$11.98
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $1.67B, an increase of 1,247.46%. That is a compound annual growth rate of 66.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.67B | 94.35% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |